XML 29 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity
 6 Months Ended
Jul. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stockholders' Equity Stockholders’ Equity
Stock option activity for the six months ended July 31, 2025 was as follows:
 Options Outstanding
 Outstanding
Stock
Options
(in millions)		Weighted-
Average
Exercise Price		Aggregate
Intrinsic Value (in millions)
Balance as of January 31, 20258 $198.89 
Exercised(1)181.56 
Balance as of July 31, 20257 $205.08 $696 
Vested or expected to vest7 $204.35 $692 
Exercisable as of July 31, 20256 $194.65 $598 
    Restricted stock activity for the six months ended July 31, 2025 was as follows:
 Restricted Stock Outstanding
 Outstanding
(in millions)		Weighted Average Grant Date Fair ValueAggregate
Intrinsic
Value (in millions)
Balance as of January 31, 202526 $250.50 
Granted - restricted stock units and awards10 279.96 
Granted - performance-based restricted stock units2 272.68 
Canceled(2)251.03 
Vested and converted to shares(8)248.36 
Balance as of July 31, 202528 $262.84 $7,161 
Expected to vest24 $6,147 
The aggregate expected stock-based compensation expense remaining to be recognized as of July 31, 2025 was as follows (in millions):
Fiscal Period:
Remaining six months of fiscal 2026$1,701 
Fiscal 20272,514 
Fiscal 20281,807 
Fiscal 2029905 
Fiscal 2030110 
Total stock-based compensation expense$7,037 
The aggregate expected stock-based compensation expense remaining to be recognized reflects only outstanding stock awards as of July 31, 2025 and assumes no forfeiture activity and no changes in the expected level of attainment of performance share grants based on the Company’s financial performance relative to certain targets.
Share Repurchase Program
The Company’s Board of Directors (the “Board”) authorized a program to repurchase shares of the Company's common stock (the "Share Repurchase Program"), which commenced in August 2022 and had additional authorizations approved by the Board in February 2023 and February 2024, for an aggregate total authorization of $30.0 billion. The Share Repurchase Program does not have a fixed expiration date and does not obligate the Company to acquire any specific number of shares. Under the Share Repurchase Program, shares of common stock may be repurchased using a variety of methods, including privately negotiated and or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as part of accelerated share repurchases and other methods. The timing, manner, price and amount of any repurchases are determined by the Company in its discretion and depend on a variety of factors, including legal requirements, price and economic and market conditions. The Company accounts for treasury stock under the cost method.
The Company repurchased the following under its Share Repurchase Program (in millions, except average price per share):
20252024
SharesAverage price per shareAmountSharesAverage price per shareAmount
Three months ended April 30,10 $273.42 $2,681 7 $293.00 $2,168 
Three months ended July 31,8 $269.96 $2,199 18 $246.14 $4,288 
All repurchases were made in open market transactions. As of July 31, 2025, the Company was authorized to purchase a remaining $5.7 billion of its common stock under the Share Repurchase Program.
In September 2025, the Board authorized an additional $20.0 billion in repurchases under the Share Repurchase Program for an aggregate total authorization of $50.0 billion.
Dividends
The Company announced the following dividends:
Quarter EndedRecord DatePayment DateDividend per ShareAmount
(in millions)
Fiscal 2026
April 30, 2025April 10, 2025April 24, 2025$0.416 $406 
July 31, 2025June 18, 2025July 10, 2025$0.416 $404 
Fiscal 2025
April 30, 2024March 14, 2024April 11, 2024$0.40 $388 
July 31, 2024July 9, 2024July 25, 2024$0.40 $388